News
12h
InvestorsHub on MSNPfizer and BioNTech Receive Positive EMA Backing for Updated COVID Vaccine
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
Daina Graybosch from Leerink Partners set a price target of 112.0 for BNTX. Skip to main content. Nasdaq+. Weekly Macro+. Scorecard. Market ... To track hedge funds' stock portfolios, ...
BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.42, a high estimate of $155.00, and a low estimate of $110.00. A negative shift in sentiment is evident ...
BioNTech (NASDAQ:BNTX – Get Free Report) had its price target lowered by investment analysts at HC Wainwright from $145.00 to $138.00 in a research note issued to investors on Monday,BenzingaNASDAQ ...
On Monday, June 2, Truist Securities analysts raised the price target on BioNTech SE (NASDAQ:BNTX) from $151 to $155 and kept a “Buy” rating. This decision came after the company entered into ...
BNTX opened at $104.40 on Thursday. The stock has a market cap of $25.10 billion, a P/E ratio of -30.71 and a beta of 1.29. The company has a debt-to-equity ratio of 0.01, a current ratio of 10.18 ...
BioNTech (BNTX) recently witnessed a 13.9% increase in its share price over the last quarter. This period saw significant executive changes, including the upcoming departure of Chief Strategy Officer ...
HC Wainwright & Co increased BioNTech SE BNTX price target from $134 to $145. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. BioNTech shares closed at $111.14 on Wednesday.
German-based BioNTech , best known for its collaboration with Pfizer during the COVID-19 pandemic for developing vaccines, found itself back in the spotlight this month. The compa ...
Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion. The merger is still awaiting ...
Asad Haider from Goldman Sachs set a price target of 110.0 for BNTX. Skip to main content. Nasdaq+. Weekly Macro+. Scorecard. Market Activity. U.S. Market Activity-> Stocks; Options; ETFs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results